Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficacy issues with antidepressants

J Fawcett1, R L Barkin

  • 1Department of Psychiatry, Rush-Presbyterian St. Luke's Medical Center, Rush Medical College, Chicago, Ill, USA.

The Journal of Clinical Psychiatry
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective spatial analysis of cases of COVID-19 in a single military accommodation block corridor, RMAS, January-March 21.

BMJ military health·2022
Same author

Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

How can schistosome circulating antigen assays be best applied for diagnosing male genital schistosomiasis (MGS): an appraisal using exemplar MGS cases from a longitudinal cohort study among fishermen on the south shoreline of Lake Malawi.

Parasitology·2019
Same author

Recent advances in the therapeutic uses of chondroitinase ABC.

Experimental neurology·2019
Same author

Mortality from Listeria monocytogenes meningoencephalitis following escalation to alemtuzumab therapy for relapsing-remitting Multiple Sclerosis.

Multiple sclerosis and related disorders·2018
Same author

The role of macrophages in the development of biliary injury in a lipopolysaccharide-aggravated hepatic ischaemia-reperfusion model.

Biochimica et biophysica acta. Molecular basis of disease·2017
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles

Antidepressant medications help two-thirds of patients, but a third may not achieve long-term response. Early patient response can predict treatment success for depression.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Psychology

Background:

  • Antidepressant medications are generally effective, with approximately two-thirds of patients showing a significant response (≥50% decrease in Hamilton Rating Scale for Depression scores).
  • Long-term studies indicate that a substantial proportion of patients (one-third or more) may not achieve or sustain a response to antidepressants, even with close monitoring and psychotherapy.

Purpose of the Study:

  • To review the efficacy of antidepressant medications.
  • To identify factors influencing treatment response in depression.
  • To discuss the limitations of traditional outcome measures in clinical trials.

Main Methods:

  • Analysis of existing clinical trial data on antidepressant efficacy.
  • Review of studies examining factors predicting treatment response.

Related Experiment Videos

  • Evaluation of traditional depression rating scales as outcome measures.

    • Main Results:

    • While overall efficacy is demonstrated, individual responses vary significantly.
    • Factors such as symptom severity, patient age, and specific symptom profiles influence antidepressant response.
    • Early patient response to medication can be a predictor of long-term outcomes.
    • Traditional efficacy measures (e.g., 50% reduction in depression scores) may not fully reflect functional improvements in daily life, such as workplace performance.

    Conclusions:

    • Antidepressant medications offer significant benefits for many individuals with depression.
    • Personalized treatment approaches considering patient-specific factors are crucial for optimizing outcomes.
    • Further research is needed to develop outcome measures that better capture functional recovery and real-world functioning.